The COVID-19 vaccine developed by AstraZeneca and Oxford University offers similar levels of protection against the new, more contagious variant first discovered in the UK when compared to previous variants, Oxford researchers said in a paper released on Friday.  The new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 infection in the […] Continue reading ->
The world’s first mix-and-match COVID-19 vaccine trial, sponsored by Oxford University, is currently recruiting volunteers to investigate the efficacy of alternating between Pfizer/BioNTech and Oxford/AstraZeneca vaccines. Meanwhile, the British GlaxoSmithKline and CureVac, a German pharmaceutical company, announced their new €150 million agreement to jointly develop a COVID-19 mRNA vaccine, attempting to address multiple emerging variants in […] Continue reading ->
AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags.  By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading ->
The World Health Organization (WHO) aims to make its engagement with non-state actors (non-state actors) more meaningful and efficient with a new proposal to establish a number of NSA fora that would allow exchange with WHO and member state representatives outside of official meetings. The new proposal — which will be tested during the 74th […] Continue reading ->
Five people have died in a major fire at the Serum Institute’s manufacturing facility, charged with producing India’s supply of the Oxford/AstraZeneca vaccine –  just days after the country’s national vaccine campaign got underway. Serum Institute Chief Executive Adar Poonawalla was quick to say that the fire at its main complex in Pune, would not […] Continue reading ->